Matinas BioPharma Holdings Inc (MTNB)
0.1711
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.1741
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Price to Book Value: 2.929 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.929 |
| May 16, 2024 | 2.981 |
| May 15, 2024 | 2.974 |
| May 14, 2024 | 3.027 |
| May 13, 2024 | 2.939 |
| May 10, 2024 | 3.025 |
| May 09, 2024 | 3.044 |
| May 08, 2024 | 3.058 |
| May 07, 2024 | 2.946 |
| May 06, 2024 | 2.894 |
| May 03, 2024 | 3.013 |
| May 02, 2024 | 3.158 |
| May 01, 2024 | 3.146 |
| April 30, 2024 | 3.199 |
| April 29, 2024 | 3.162 |
| April 26, 2024 | 3.082 |
| April 25, 2024 | 3.127 |
| April 24, 2024 | 3.132 |
| April 23, 2024 | 3.127 |
| April 22, 2024 | 3.101 |
| April 19, 2024 | 3.234 |
| April 18, 2024 | 3.274 |
| April 17, 2024 | 3.308 |
| April 16, 2024 | 3.444 |
| April 15, 2024 | 3.489 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.501 |
| April 11, 2024 | 3.475 |
| April 10, 2024 | 3.601 |
| April 09, 2024 | 3.668 |
| April 08, 2024 | 3.601 |
| April 05, 2024 | 3.666 |
| April 04, 2024 | 3.278 |
| April 03, 2024 | 3.399 |
| April 02, 2024 | 5.229 |
| April 01, 2024 | 5.524 |
| March 28, 2024 | 3.062 |
| March 27, 2024 | 3.276 |
| March 26, 2024 | 3.228 |
| March 25, 2024 | 3.279 |
| March 22, 2024 | 3.141 |
| March 21, 2024 | 3.008 |
| March 20, 2024 | 3.254 |
| March 19, 2024 | 3.207 |
| March 18, 2024 | 3.079 |
| March 15, 2024 | 3.387 |
| March 14, 2024 | 2.688 |
| March 13, 2024 | 2.879 |
| March 12, 2024 | 2.935 |
| March 11, 2024 | 3.059 |
| March 08, 2024 | 3.048 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.975
Minimum
Sep 25 2023
12.97
Maximum
Jan 02 2020
3.452
Average
3.182
Median
Sep 23 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| PS Ratio | 8.620 |
| Price | 0.1711 |
| Earnings Yield | -70.59% |
| Market Cap | 42.64M |